Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Wnt signaling networks in autism spectrum disorder and intellectual disability.

Kwan V, Unda BK, Singh KK.

J Neurodev Disord. 2016 Dec 5;8:45. eCollection 2016. Review.

2.

Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.

Renard J, Loureiro M, Rosen LG, Zunder J, de Oliveira C, Schmid S, Rushlow WJ, Laviolette SR.

J Neurosci. 2016 May 4;36(18):5160-9. doi: 10.1523/JNEUROSCI.3387-15.2016.

3.

Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.

Pan B, Huang XF, Deng C.

Int J Mol Sci. 2016 Mar 28;17(4):459. doi: 10.3390/ijms17040459.

4.

Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.

Pan B, Chen J, Lian J, Huang XF, Deng C.

PLoS One. 2015 Jul 10;10(7):e0132722. doi: 10.1371/journal.pone.0132722. eCollection 2015.

5.

Potential molecular and cellular mechanism of psychotropic drugs.

Seo MS, Scarr E, Lai CY, Dean B.

Clin Psychopharmacol Neurosci. 2014 Aug;12(2):94-110. doi: 10.9758/cpn.2014.12.2.94. Epub 2014 Aug 12. Review.

6.

Human endogenous retroviruses and the nervous system.

Douville RN, Nath A.

Handb Clin Neurol. 2014;123:465-85. doi: 10.1016/B978-0-444-53488-0.00022-5. Review. No abstract available.

7.

Wnts in adult brain: from synaptic plasticity to cognitive deficiencies.

Oliva CA, Vargas JY, Inestrosa NC.

Front Cell Neurosci. 2013 Dec 3;7:224. doi: 10.3389/fncel.2013.00224. Review.

8.

A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation.

Martin PM, Yang X, Robin N, Lam E, Rabinowitz JS, Erdman CA, Quinn J, Weiss LA, Hamilton SP, Kwok PY, Moon RT, Cheyette BN.

Transl Psychiatry. 2013 Sep 3;3:e301. doi: 10.1038/tp.2013.75.

9.

The wnt pathway in mood disorders.

Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM, Simonetti A, Caloro M, Girardi N, Telesforo CL, Serra G, Romano S, Manfredi G, Savoja V, Tamorri SM, Koukopoulos AE, Serata D, Rapinesi C, Del Casale A, Nicoletti F, Girardi P.

Curr Neuropharmacol. 2012 Sep;10(3):239-53. doi: 10.2174/157015912803217279.

10.

Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.

Urs NM, Snyder JC, Jacobsen JP, Peterson SM, Caron MG.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20732-7. doi: 10.1073/pnas.1215489109. Epub 2012 Nov 27.

11.

LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6.

Berwick DC, Harvey K.

Hum Mol Genet. 2012 Nov 15;21(22):4966-79. doi: 10.1093/hmg/dds342. Epub 2012 Aug 16.

12.

A mega-analysis of genome-wide association studies for major depressive disorder.

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, Martin NG, McGuffin P, Muglia P, Noethen MM, Penninx BP, Pergadia ML, Potash JB, Rietschel M, Lin D, Müller-Myhsok B, Shi J, Steinberg S, Grabe HJ, Lichtenstein P, Magnusson P, Perlis RH, Preisig M, Smoller JW, Stefansson K, Uher R, Kutalik Z, Tansey KE, Teumer A, Viktorin A, Barnes MR, Bettecken T, Binder EB, Breuer R, Castro VM, Churchill SE, Coryell WH, Craddock N, Craig IW, Czamara D, De Geus EJ, Degenhardt F, Farmer AE, Fava M, Frank J, Gainer VS, Gallagher PJ, Gordon SD, Goryachev S, Gross M, Guipponi M, Henders AK, Herms S, Hickie IB, Hoefels S, Hoogendijk W, Hottenga JJ, Iosifescu DV, Ising M, Jones I, Jones L, Jung-Ying T, Knowles JA, Kohane IS, Kohli MA, Korszun A, Landen M, Lawson WB, Lewis G, Macintyre D, Maier W, Mattheisen M, McGrath PJ, McIntosh A, McLean A, Middeldorp CM, Middleton L, Montgomery GM, Murphy SN, Nauck M, Nolen WA, Nyholt DR, O'Donovan M, Oskarsson H, Pedersen N, Scheftner WA, Schulz A, Schulze TG, Shyn SI, Sigurdsson E, Slager SL, Smit JH, Stefansson H, Steffens M, Thorgeirsson T, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Völzke H, Weilburg JB, Willemsen G, Zitman FG, Neale B, Daly M, Levinson DF, Sullivan PF.

Mol Psychiatry. 2013 Apr;18(4):497-511. doi: 10.1038/mp.2012.21. Epub 2012 Apr 3.

13.

Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development.

Singh KK, De Rienzo G, Drane L, Mao Y, Flood Z, Madison J, Ferreira M, Bergen S, King C, Sklar P, Sive H, Tsai LH.

Neuron. 2011 Nov 17;72(4):545-58. doi: 10.1016/j.neuron.2011.09.030.

14.

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors.

Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR.

Front Mol Neurosci. 2011 Nov 1;4:38. doi: 10.3389/fnmol.2011.00038. eCollection 2011.

15.

A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

Beaulieu JM.

J Psychiatry Neurosci. 2012 Jan;37(1):7-16. doi: 10.1503/jpn.110011. Review.

16.

Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance.

Panariello F, Perruolo G, Cassese A, Giacco F, Botta G, Barbagallo AP, Muscettola G, Beguinot F, Formisano P, de Bartolomeis A.

J Cell Physiol. 2012 Apr;227(4):1485-92. doi: 10.1002/jcp.22864.

17.

Synaptic Wnt signaling-a contributor to major psychiatric disorders?

Okerlund ND, Cheyette BN.

J Neurodev Disord. 2011 Jun;3(2):162-74. doi: 10.1007/s11689-011-9083-6. Epub 2011 Apr 28.

18.

Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation.

Yoon S, Choi MH, Chang MS, Baik JH.

J Biol Chem. 2011 May 6;286(18):15641-51. doi: 10.1074/jbc.M110.188078. Epub 2011 Mar 15.

19.

GSK-3β activity and hyperdopamine-dependent behaviors.

Li YC, Gao WJ.

Neurosci Biobehav Rev. 2011 Jan;35(3):645-54. doi: 10.1016/j.neubiorev.2010.08.001. Epub 2010 Aug 18. Review. Erratum in: Neurosci Biobehav Rev. 2013 Mar;37(3):549.

20.

Supplemental Content

Support Center